Chronic Diseases

By Marvin Stein; Andrew Baum | Go to book overview
Save to active project

3
Experimental Therapeutics of Alzheimer's Disease

Brian A. Lawlor

Trinity College, Dublin

In spite of the dramatic increase in our knowledge about Alzheimer's disease (AD) over the past 25 years, the cause of this illness (or illnesses) and its exact pathogenesis still eludes us. Great advances have been made in uncovering the ultrastructure of the beta-amyloid and the neurofibrillary tangles that constitute the pathognomonic neuropathological feature of this illness; however, these great discoveries have not yet translated into meaningful developments in the therapeutics of this devastating illness. Furthermore, the absence of an animal model for AD has slowed the development of compounds that might be effective in the treatment of this illness. In spite of these drawbacks, the therapeutics of AD is an active and expanding area of research. In this chapter, the various psychopharmacological approaches that are currently being explored are reviewed, and new developments and their potential application in the next 5-10 years are discussed.


CHOLINERGIC AUGMENTATION STRATEGIES

The use of agents that act on cholinergic transmission has been the mainstay of the psychopharmacological approach to the treatment of AD in the past 10-15 years. The early work of Drachman and Leavitt ( 1974) with scopolamine (a muscarinic antagonist), demonstrating that cholinergic blockade in young normals mimicked the memory loss of old age, suggested that the cholinergic system had a central role in memory. Following quickly on this finding was the report that choline acetyl transferase (ChAT), an enzyme necessary for the synthesis of acetylcholine, was decreased in the cortex of patients dying from AD

-45-

Notes for this page

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this page

Cited page

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited page

Bookmark this page
Chronic Diseases
Table of contents

Table of contents

Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this book

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen
/ 344

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?